Ductal carcinoma in situ Part 2: Treatment

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 4, 1997, Pages 157-165

  Delaney, Geoff ^a   Uno, Owen ^b   Cahill, Stephen ^c   Bilous, Michael ^d,e   Boyages, John ^e,f  

^a Division of Radiation Oncology   (Australia)

^b Department of Surgery ^*  (Australia)

^c Division of Radiology   (Australia)

^d Western Sydney Area Health Service   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f LIVERPOOL HOSPITAL   (Australia)

Author keywords

breast; conservative surgery; DCIS; lumpectomy; mastectomy; radiotherapy; tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME;

EID: 0030894112     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb01931.x     Document Type: Review

References (83)

1. Fisher B, Redmond C, Poisson R et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1989; 320: 822-8.
2. Sarrazin D, Le MG, Arriagada R et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother. Oncol. 1989; 14: 177-84.
3. Veronesi U, Banfi A, Salvador! B et al. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial. Eur. J. Cancer 1990; 26: 668-70.
4. Lichter AS, Lippman ME, Danforth DN Jr et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J. Clin. Oncol. 1992; 10: 976-83.
5. van Dongen JA, Bartelink H, Fentiman IS et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J. Natl Cancer Inst. 1992; 11:15-18.
6. Blichert-Toft M, Rose C, Andersen JA et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J. Natl Cancer Inst. 1992; 11: 19-25.
7. Winchester DP, Menck HR, Osteen RT, Kraybill W. Treatment trends for ductal carcinoma in situ of the breast. Ann. Surg. Oncol. 1995; 2: 207-13.
8. Delaney G, Ung O, Bilous M, Cahill S, Greenberg ML, Boyages J. Ductal carcinoma in situ Part 1: Definition and diagnosis. Aust. N.Z. J. Surg. 1997; 67: 81-93.
9. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 1982; 49: 751-8.
10. Betsill WL, Rosen PP, Lieberman PH, Robbins GF. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978; 239: 1863-7.
11. Rosen PP, Braun DW, Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer 1980; 46: 919-25.
12. Eusebi V, Foschini MP, Cook MG, Berrino F, Azzopardi JG. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin. Diagn. Pathol. 1989; 6: 165-73.
13. Eusebi V, Feudale E, Foschini MP et al. Long-term follow-up of in situ carcinoma of the breast. Semin. Diagn. Pathol. 1994; 11: 223-35.
14. Ashikari R, Hajdu SI, Robbins GF. Intraductal carcinoma of the breast (1960-1969). Cancer 1971; 28: 1182-7.
15. Arnesson LG, Smeds S, Fagerberg G, Grontoft O. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br. J. Surg. 1989; 76: 672-5.
16. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: The relevance of histologie categorization. Hum. Pathol. 1993; 24: 16-23.
17. Brown PW, Silverman J, Owens E, Tabor DC, Terz JJ, Lawrence WJ. Intraductal 'noninfiltrating' carcinoma of the breast. Arch. Surg. 1976; 111: 1063-7.
18. Carpenter R, Boulter PS, Cooke T, Gibbs NM. Management of screen detected ductal carcinoma in situ of the female breast. Br. J. Surg. 1989; 76: 564-7.
19. Cataliotti L, Distante V, Ciatto S et al. Intraductal breast cancer: Review of 183 consecutive cases. Eur. J. Cancer 1992; 28A: 917-20.
20. Ciatto S, Bonardi R, Cataliotti L, Cardona G. Intraductal breast carcinoma. Review of a multicenter series of 350 cases. Tumori 1990; 76: 552-4.
21. Cutuli B, Teissier E, Piat JM et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur. J. Cancer 1992; 28: 649-54.
22. Farrow JH. The James Evving lecture-current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer 1970; 25: 468-77.
23. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6) I. Intraductal Carcinoma (DCIS). Cancer 1986; 57: 197-208.
24. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen PP. Breast carcinoma in situ. Arch. Surg. 1989; 124: 33-6.
25. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node métastases and short-term treatment failures. Cancer 1982; 50: 1309-14.
26. Millis RR, Thynne GSJ. In situ intraduct carcinoma of the breast: A long term follow-up study. Br. J. Surg. 1975; 62: 957-62.
27. Montague ED. Conservation surgery and radiation therapy in the treatment of operable breast cancer. Cancer 1984; 53: 700-4.
28. Price P, Sinne HD, Gusterson B, Walsh G, A'hern RP, McKinna JA. Duct carcinoma iij situ: Predictors of local recurrence and progression in patients treated by surgery alone. Br. J. Cancer 1990; 61: 869-72.
29. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch. Snrg. 1986; 121: 1303-7.
30. Silverstein MJ, Cohlan BF, Gierson ED et al. Duct carcinoma in situ: 227 cases without microinvasion. Eiir. J. Cancer 1992; 28: 630-4.
31. Sunshine JA, Moseley HS, Fletcher WS, Krippaehne WW. Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. Am. J. Surg. 1985; 150: 44-51.
32. Temple WJ, Jenkins M, Alexander F et al. Natural history of in situ breast cancer in a defined population. Ann. Surg. 1989; 210: 653-7.
33. von Rueden DG, Wilson RE. Intraductal carcinoma of the breast. Surgery 1984; 158: 105-11.
34. Westbrook KC, Gallager HS. Intraductal carcinoma of the breast. A comparative study. Am. J. Surg. 1975; 130: 667-70.
35. Silverstein MJ, Gierson ED, Colburn WJ, Rosser RJ, Waisman JR, Gamagami P. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg. Gynecol. Obstet. 1991; 172: 211-14.
36. Silverstein MJ, Rosser RJ, Gierson ED et al. Axillary lymph node dissection for intraductal breast carcinoma-is it indicated? Cancer 1987; 59: 1819-24. '
37. Hiramatsu H, Bornstein BA, Recht A et al. Outcome and risk factors for local failure after conservative surgery and radiotherapy for ductal carcinoma in situ. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30 (Suppl. 1): 153 (Abstract).
38. Tinnemans JGM, Wobbes T, Holland R, Hendriks JHCL, van der Sluis RF, De Boer HHM. Treatment and survival of female patients with nonpalpable breast carcinoma. Ann. Surg. 1989; 209: 249-53.
39. Rosner D, Bedwani RN, Vana PHJ, Baker HW, Murphy GP. Noninvasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann. Surg. 1980; 192: 139-47.
40. Baird RM, Worth A, Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am. J. Surg. 1990; 159: 479-81.
41. Fisher B, Constantino J, Redmond C et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl.J.Med. 1993;328:1581-6.
42. Gallagher WJ, Koerner FC, Wood WC. Treatment of intraductal carcinoma with limited surgery: Long-term follow-up. J. Clin. Oncol. 1989; 7: 376-80.
43. Kuske RR, Bean JM, Garcia DM et al. Breast conservation therapy for intraductal carcinoma of the breast. Int. J. Radiat. Oncol. Biol. Phys. 1993; 26: 391-6.
44. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618-24.
45. Ottesen GL," Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma i/i situ of the female breast. Short term results of a prospective nation wide study. Am. J. Surg. Patlwl. 1992; 16: 1183-96.
46. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 1992; 70: 2468-574.
47. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? A study of 14731 women with breast cancer from the cancer registry of Norway. Cancer 1984; 53: 1793-800.
48. Bullock CG, Magnant C, Ayoob M et al. The utility of conservative surgery and radiation therapy in ductal carcinoma HI Ji/ii. Int. J. Radial. Oncol. Biol. Phys. 1993; 27: (Suppl. 1) 268 (Abstract).
49. Fourquet A, Zafrani B, Campana F, Durand J, Vilcoq JR. Breast-conserving treatment of ductal carcioma in situ. Semin. Radiat. Oncol. 1992; 2: 116-24.
50. Fowble B. Intraductal noninvasive breast cancer: A comparison of three local treatments. Oncology 1989; 3: 51-8.
51. Kurtz JM, Jacquemier J, Torhorst J et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989; 63: 1630-5.
52. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: An analysis of local control after conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1991; 21: 289-92.
53. Ray GR, Adelson J, Hayhurst E et al. Ductal carcinoma in situ of the breast: Results of treatment by conservative surgery and definitive irradiation. //;J. J. Radiat. Oncol. Biol. Phys. 1994; 28: 105-11.
54. Solin LJ, Fowble BL, Schultz DJ, Yeh I, Kowalyshyn MJ, Goodman RL. Definitive irradiation for intraductal carcinoma of the breast. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 843-50.
55. Stotter AT, McNeese M, Oswald MJ, Ames FC, Romsdahl MM. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1990; 18: 283-7.
56. White J, Levine A, Gustafson G et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 791-7.
57. Solin L, Kurtz J, Fourquet A et al. Fifteen year outcome of conservation surgery and radiotherapy (CS & RT) for ductal carcinoma i situ (DCIS). Proc. Am. Soc. Clin. Oncol. 1995; 14: 107.
58. Solin LJ, Yeh IT, Kurtz J et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breastconserving surgery and definitive irradiation. Cancer 1993; 71: 2532-42.
59. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B, Collaborating NSABP Investigators. Conservative management of intraductal carcinoma (DCIS) of the breast. J. Surg. Oncol. 1991; 47: 139-47.
60. Bornstein BA, Recht A, Connolly JL et al. Results of treating ductal carcinoma in Vu of the breast with conservative surgery and radiation therapy. Cancer 1991; 67: 7-13.
61. Solin LJ, Recht A, Fourquet A et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 1991; 68: 2337-44.
62. Archer SG, Kemp BL, Gadd M, Shallenberger R, Ames FC, Singletary SE. Ductal carcinoma in situ of the breast: Comedo versus noncomedo subtype nonpredictive of recurrence or contralateral new breast primary. Breast Dis. 1994; 7: 353-60.
63. Ringberg A, Idvall I, Anagnostaki L et al. Morphological and clinical characteristics in patients with ipsilateral recurrence after DCIS. Eur. J. Cancer 1994; 30A (Suppl. 2): 574 (Abstract).
64. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 1310-19.
65. Silverstein MJ, Gierson ED, Colburn WJ et al. Can intraductal breast carcinoma be excised completely by local excision? Cancer 1994; 73: 2985-9.
66. Bobrow LG, Millis RR. The pathology of ductal carcinoma in situ of the breast. Clin. Oncol. 1995; 7: 232-5.
67. Faverly DRG, Burgers L, Bull P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications. Semin. Diagn. Pathol. 1994; 11: 193-8.
68. Holland R, Hendriks JHCL. Microcalcifications associated with ductal carcinoma in situ: Mammographie-pathologie correlation. Semin. Diagn. Pathol 1994; 11: 181-92.
69. Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA. Consequences of breast irradiation in patients with preexisting collagen vascular diseases. Int. J. Radiat. Oncol. Biol. Phys. 1989; 17: 829-33.
70. Robertson JM, Clarke DH, Pevzner MM, Matter RC. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 1991; 68: 502-8.
71. Silverstein MJ, Polier DN, Waisman JR et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-7.
72. Silverstein MJ, Lagios MD, Craig PH et al. The Van Nuys prognostic index for ductal carcinoma in situ. Breast J. 1996; 2: 38-40.
73. Sadowsky NL, Semine A, Harris JR. Breast imaging. A critical aspect of breast conserving treatment. Cancer 1990; 65: 2113-18.
74. Hassall PR, Olivotto IA, Mueller HA, Kingston GW, Basco VE. Early breast cancer: Detection of recurrence after conservative surgery and radiation therapy. Radiology 1990; 176: 731-5.
75. Greenstein S, Troupin RH, Patterson EA, Fowble BL. Breast cancer recurrence after lumpectomy and irradiation: Role of mammography in detection. Radiology. 1992; 183: 201-6.
76. Locker AP, Hanley P, Wilson AR et al. Mammography in the pre-operative assessment and post-operative surveillance of patients treated by excision and radiotherapy for primary breast cancer. Clin. Radial. 1990; 41: 388-91.
77. Mitnick JS, Vazquez MF, Roses DF, Harris MN, Schlechter S. Recurrent breast cancer: Stereotaxic localization for fine-needle aspiration biopsy. Radiology 1992; 182: 103-6.
78. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumour recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadoliniumenhanced MR imaging. Radiology 1993; 187: 751-5.
79. Gilles R, Guinebretiere JM, Shapeero LG et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients. Radiology 1993; 188: 473-88.
80. Solin LJ, Fourquet A, McCormick B et al. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int. J. Radiat. Oncol. Dial. Phys. 1994; 30: 3-9.
81. Recht A, van Dongen JA, Fentiman IS, Holland R, Peterse JL. Third meeting of the DCIS working party of the EORTC (Fondazione Cini, Isola S Giorgio, Venezia, 28 February 1994)Conference report. Eur. J. Cancer 1994; 30A: 1895-900.
82. Spittle M, Stewart HJ. Non-surgical management of early breast cancer in the United Kingdom: Ductal carcinoma in situ. Clin. Oncol. 1995; 7: 217-18.
83. Girgis A, Sanson-Fisher RW. Breaking bad news: Consensus guidelines for medical practitioners. J. Clin. Oncol. 1995; 13: 2449-56.